NF1-related breast cancers are associated with adverse prognostic factors, aggressive molecular subtypes (HER2+ and triple-negative breast cancers), and decreased overall survival compared to sporadic breast cancer (Uusitalo et al., 2017). This evidence concerns the gene ERBB2 and breast cancer.